Bernard Bochner, MD
Urology · New York, NYNPI 1558347161
Payments from drug & device makers
Across 129 payments — averaging $645.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Corporation Of The Americas$70K
- Janssen Scientific Affairs, LLC$4K
- Astellas Pharma US Inc$2K
- Olympus Winter & Ibe GmbH$2K
- Johnson & Johnson$1K
- Olympus Corporation$1K
- plus $2K from 6 others
What the payments were for
- Consulting fees$9,04011%
- Speaking & faculty fees$1,4852%
- Travel & lodging$3,8315%
- Food & beverage$1,8322%
- Education$67,06681%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Corporation Of The Americas | 101 | $70,475 |
| Janssen Scientific Affairs, LLC | 11 | $3,869 |
| Astellas Pharma US Inc | 2 | $2,238 |
| Olympus Winter & Ibe GmbH | 2 | $1,890 |
| Johnson & Johnson | 1 | $1,350 |
| Olympus Corporation | 2 | $1,215 |
| Gyrus ACMI, Inc. | 1 | $730 |
| Baxter Healthcare | 4 | $571 |
| Olympus Medical Systems Corporation | 1 | $540 |
| Genentech USA, Inc. | 1 | $149 |
| Clovis Oncology, Inc. | 2 | $134 |
| Seagen Inc. | 1 | $94 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OES CYSTONEPHROFIBERSCOPE$50,512
- CYSTO-NEPHRO VIDEOSCOPE$49,983
- HD CAMERA HEAD$35,316
- HD 3CMOS AUTOCLAVABLE CAMERA HEAD$20,596
- Olympus$20,596
- Single Use Grasping Forceps FG-253SX$18,193
- Olympus Cystoscopes$13,699
- Olympus Laser Devices$13,699
- Olympus Resection Disposables$13,699
- PADCEV$2,238
- FLOSEAL$291
- TECENTRIQ$149
- PERI-STRIPS DRY$142
- TISSEEL$142
How this compares
$83,254 in reported general payments places this provider in the 90th percentile of 952 urology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 37 | $338 |
| Finasteride | 13 | $291 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $90 |
| Ciprofloxacin Hcl | 15 | $57 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $33 |
| Amoxicillin | 14 | $33 |
Paid to pharmacies, not to this prescriber.
Other urology in New York
- Guarionex DecastroNew York$5.7M
- James McKiernanNew York$4.1M
- William HuangNew York$3.9M
- Ashutosh TewariNew York$2.5M
- Bilal ChughtaiNew York$1.5M
- Nils Peter WiklundNew York$1M
- Herbert LeporNew York$823K
- Christopher AndersonNew York$785K
- Katie MurrayNew York$776K
- John SfakianosNew York$726K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.